| Literature DB >> 25289072 |
Tiantian Wu1, Jing Chen2, Jiang Zhu1, Zhen Yu3.
Abstract
Leucine (Leu), a branched-chain amino acid (BCAA), is widely used in clinical practice following severe burns, gastrointestinal surgery, trauma and sepsis. In the present study, the antifatigue effects of BCAAs on a postoperative fatigue (POF) rat model, induced by 70% intestinal resection, were investigated. Leu (16.5 g/l) was administered intraperitoneally at a dose of 18 ml/kg/day. The fatigue level and antifatigue effects of Leu were evaluated by open-field testing on day 1, 3, 5 and 7 after surgery. In addition, mRNA specimens were extracted and measured using a quantitative polymerase chain reaction method. The open-field test results indicated that Leu exhibited a significant antifatigue effect. The total distance travelled and the number of times the rats passed from the outermost grids of an open-top case were greatly improved in the Leu treatment group when compared with the POF model group. With the exception of the normal group, the mRNA expression levels of Htr-1a exhibited a similar trend in all other groups, reaching a climax on day 3 and 5, while being restored to a normal level on day 7. With regard to the Leu intervention group, the mRNA expression level of Htr-1a decreased significantly on day 3 and 5 following surgery. The mRNA expression levels of tryptophan hydroxylase-1 were unchanged in this short time period; however, the levels were increased gradually in the Leu treatment group. Therefore, Leu exhibited an apparent antifatigue effect on various 5-hydroxytryptamine-associated genes.Entities:
Keywords: Htr-1a; leucine; open-field test; postoperative fatigue; quantitative polymerase chain reaction; tryptophan hydroxylase-1
Year: 2014 PMID: 25289072 PMCID: PMC4186329 DOI: 10.3892/etm.2014.1973
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1Mesenteric vessels were ligated, 70% of the intestine was cut and the remnant was anastomosed.
Sequences of the Htr-1a and TPH-1 genes.
| Gene name | Sense sequence (5′-3′) | Antisense sequence (5′-3′) |
|---|---|---|
| Htr-1a | gtgccggcctgctttcttcc | gcgctggttatgctcttgctgtct |
| TPH-1 | atggggcagtgaggcagggtgacg | ccaagcaggcgggggcataggagt |
| GAPDH | ggtgctgagtatgtcgtgga | gccatgccagtgagcttccc |
TPH-1, tryptophan hydroxylase-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Results of the open-field test.
| Horizontal movement | Vertical movement | |||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Groups | Rats (n) | Total distance travelled (m) | Times passing from the outermost grids (n) | Times passing from central square (n) | Explorations (n) | Clean ups (n) |
| NG-D1 | 8 | 19.00±3.79 | 104.4±42.2 | 2.0±0.8 | 12.6±7.4 | 2.8±2.1 |
| NG-D3 | 8 | 17.24±4.76 | 112.4±38.9 | 2.1±1.1 | 14.3±6.2 | 2.6±1.2 |
| NG-D5 | 8 | 18.36±5.21 | 96.59±26.0 | 1.8±1.0 | 16.8±4.7 | 1.8±1.6 |
| NG-D7 | 8 | 21.6±3.86 | 117.5±19.8 | 2.0±1.2 | 12.6±6.5 | 2.6±1.4 |
| SG-D1 | 8 | 11.51±2.66 | 71.1±13.9 | 2.1±1.1 | 6.4±3.9 | 1.9±1.7 |
| SG-D3 | 8 | 15.33±2.85 | 104.9±21.8 | 1.6±0.9 | 12.4±5.0 | 2.6±2.4 |
| SG-D5 | 8 | 19.12±2.40 | 139.0±31.7 | 2.0±1.1 | 13.0±5.8 | 3.6±2.8 |
| SG-D7 | 8 | 18.42±3.93 | 121.5±24.8 | 1.8±1.0 | 17.3±6.2 | 3.5±2.2 |
| MG-D1 | 8 | 10.52±4.98 | 60.0±18.9 | 1.1±0.4 | 4.6±2.6 | 2.6±2.4 |
| MG-D3 | 8 | 9.75±2.59 | 69.3±19.0 | 0.5±0.5 | 9.0±4.0 | 2.1±1.7 |
| MG-D5 | 8 | 12.69±2.07 | 118.0±15.7 | 1.0±0.0 | 13.4±5.4 | 3.3±1.7 |
| MG-D7 | 8 | 17.34±3.50 | 139.3±23.9 | 1.3±0.5 | 15.9±6.9 | 3.3±2.4 |
| LG-D1 | 8 | 9.06±2.06 | 61.4±16.1 | 0.9±0.4 | 5.9±2.2 | 3.9±2.5 |
| LG-D3 | 8 | 11.11±3.06 | 77.9±24.5 | 0.8±0.5 | 9.9±3.3 | 2.9±1.4 |
| LG-D5 | 8 | 19.82±2.42 | 136.4±19.1 | 0.9±0.6 | 15.1±4.9 | 5.1±3.4 |
| LG-D7 | 8 | 23.21±3.63 | 153.3±23.4 | 1.0±0.5 | 19.6±6.9 | 4.9±3.5 |
Results are expressed as mean ± standard deviation.
P<0.05, vs. NG-D1
P<0.05, vs. MG at the same parameter.
NG, normal group; SG, sham operation group; MG, POF model group; LG, Leu-treated POF model group; Dn, day n (where n=1,3,5 or 7); Leu, leucine.
Results of qPCR.
| Groups | Rats (n) | Htr-1a | TPH-1 |
|---|---|---|---|
| MG-D1 | 8 | 1.0364±0.3998 | 1.4710±0.6517 |
| MG-D3 | 8 | 40.1413±14.5137 | 0.8461±0.6696 |
| MG-D5 | 8 | 21.8495±7.8794 | 1.4303±0.9012 |
| MG-D7 | 8 | 1.5624±1.5698 | 3.1004±1.4620 |
| SG-D1 | 8 | 1.5274±1.3713 | 2.9534±1.2771 |
| SG-D3 | 8 | 47.2402±19.7972 | 0.6509±0.2823 |
| SG-D5 | 8 | 25.6668±8.6453 | 1.3636±0.5345 |
| SG-D7 | 8 | 1.2369±0.9885 | 0.8305±0.4100 |
| LG-D1 | 8 | 1.4380±1.1323 | 1.2571±0.9843 |
| LG-D3 | 8 | 25.3650±6.3114 | 5.6938±1.0210 |
| LG-D5 | 8 | 11.2531±3.7433 | 10.2159±1.2561 |
| LG-D7 | 8 | 1.2406±1.2125 | 11.1382±1.3120 |
Relative expression levels were calculated using the 2−ΔΔCt method and are expressed as the mean ± standard deviation.
P>0.05, between day 1 and 7 after surgery
P>0.05, between day 3 and 5 after surgery
P<0.05, vs. MG values. For the TPH-1 gene, the values of LG-D5 and LG-D7 were higher compared with the other subgroups (P<0.05); however, there was no significant difference between the values at D5 and D7 (P>0.05).
SG, sham operation group; MG, POF model group; LG, Leu-treated POF model group; Dn, day n (where n=1,3,5 or 7); qPCR, quantitative polymerase chain reaction; TPH-1, tryptophan hydroxylase-1; Leu, leucine.